InvestorsHub Logo
Followers 87
Posts 1159
Boards Moderated 0
Alias Born 09/10/2017

Re: hoffmann6383 post# 450692

Saturday, 03/12/2022 3:04:38 PM

Saturday, March 12, 2022 3:04:38 PM

Post# of 700474

That is what is happening right now. Advertising and a slow ramp.


Advent didn’t begin manufacturing until February because they had to perform some validation work after licensing. From the 10K:

During 2021, work continued for technology transfer from the London facility to the Sawston facility, recruitment of contract technical personnel for Sawston, development of some 1,000 regulatory documents for operations in the Sawston facility, and applications to both the Human Tissue Authority (HTA) and the MHRA for inspections of the Sawston facility and its operations, and issuance of licenses for manufacturing in the facility. These applications and inspections were successfully completed.  The HTA license was issued in October 2021 and the MHRA license was issued in December 2021. Following some required validation work after the licenses were issued, production of DCVax-L began this month.


And by the way, ex is right. Northwest Bio can not advertise an unlicensed medicinal product for UK “specials.”


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News